Author

Jorge Kalil

Professor of Clinical Immunology and Allergy, Director Laboratory of Immunology Heart Institute - Cited by 18,462

Biography

Jorge Kalil is Professor of Clinical Immunology and Allergy at the School of Medicine, University of Sao Paulo. He is a Distinguished Visiting Professor at Harvard Medical School and Harvard School of Public Health until September 2019. He graduated in Medicine in Brazil and received his Doctor of Sciences degree from Jean Dausset’s Laboratory, Nobel Laureate for the discovery of HLA, in Paris. He has 400 publications listed on PubMed in diverse areas of immunology. He was an International Scholar of the Howard Hughes Medical Institute, Visiting Professor at Stanford Medical School, Director of the Butantan Institute
Title
Cited by
Year
Reduced T cell and antibody responses to inactivated coronavirus vaccine among individuals above 55 years old
GX Medeiros, GL Sasahara, JY Magawa, JPS Nunes, FR Bruno, ...Frontiers in immunology 13, 812126, 2022202
17
2022
Recessive NLRC4-Autoinflammatory Disease Reveals an Ulcerative Colitis Locus
A Steiner, T Reygaerts, A Pontillo, I Ceccherini, J Moecking, F Moghaddas, ...Journal of Clinical Immunology, 1-11, 2022202
12
2022
Effects of oxysterols on immune cells and related diseases
FA de Freitas, D Levy, CO Reichert, E Cunha-Neto, J Kalil, SP BydlowskiCells 11 (8), 1251, 2022202
10
2022
Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein
JT Castro, P Azevedo, MJ Fumagalli, NS Hojo-Souza, N Salazar, ...Nature Communications 13 (1), 4831, 2022202
6
2022
Matrix metalloproteinase 2 and 9 enzymatic activities are selectively increased in the myocardium of Chronic Chagas Disease cardiomyopathy patients: role of TIMPs
MA Baron, LRP Ferreira, PC Teixeira, AIS Moretti, RHB Santos, AF Frade, ...Frontiers in cellular and infection microbiology 12, 249, 2022202
5
2022
MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil
EC Castelli, MV de Castro, MS Naslavsky, MO Scliar, NSB Silva, ...Frontiers in Immunology 13, 975918, 2022202
4
2022
Worsening of asthma control after COVID-19
RC Agondi, N Menechino, AKBB Marinho, J Kalil, P Giavina-BianchiFrontiers in medicine 9, 882665, 2022202
4
2022
Recurrence of COVID-19 associated with reduced T-cell responses in a monozygotic twin pair
MV De Castro, KS Santos, JS Apostolico, ER Fernandes, RR Almeida, ...Open Biology 12 (2), 21020, 2022202
4
2022
Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape
JR Oliveira, CMR Ruiz, RRG Machado, JY Magawa, IP Daher, ...Frontiers in Immunology 1, 1010105, 20220
3
2023
Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi In Vitro and In Vivo
RP Pandey, MS Nascimento, CH Franco, K Bortoluci, MN Silva, ...Antimicrobial Agents and Chemotherapy 66 (11), e0084-, 0
2
2022
Liver disease accompanied by enteropathy in common variable immunodeficiency: Common pathophysiological mechanisms
FMS Lima, M Toledo-Barros, VAF Alves, MIS Duarte, C Takakura, ...Frontiers in Immunology 13, 933463, 0
2
2022
Epigenetic regulation of transcription factor binding motifs promotes Th1 response in Chagas disease cardiomyopathy
P Brochet, BM Ianni, L Laugier, AF Frade, JP Silva Nunes, PC Teixeira, ...Frontiers in Immunology 13, 4536, 0
2
2022
The oldest unvaccinated Covid-19 survivors in South America
MV de Castro, MVR Silva, MS Naslavsky, MO Scliar, K Nunes, ...Immunity & Ageing 19 (1), 57, 0
2
2022
Basophil Activation Test as a Biomarker for Taxanes Anaphylaxis
L De Campos, P Giavina-Bianchi, S Acharya, DM Lynch, J Kalil, ...Frontiers in Allergy 3, 787749, 2022202
1
2022
Plasmablast expansion following the tetravalent, live-attenuated dengue vaccine Butantan-DV in DENV-Naïve and DENV-exposed individuals in a Brazilian cohort
CGT Silveira, DM Magnani, PR Costa, VI Avelino-Silva, MJ Ricciardi, ...Frontiers in immunology 3, 908398, 2022202
1
2022
A Major Downregulation of Circulating microRNAs in Zika Acutely Infected Patients: Potential Implications in Innate and Adaptive Immune Response Signaling Pathways
AC Carvalho-Silva, AR Da Silva Junior, VOC Rigaud, WK Martins, ...Frontiers in Genetics 3, 857728, 2022202
1
2022
Systemic amyloidosis journey from diagnosis to outcomes: a twelve-year real-world experience of a single center in a middle-income country
RS Szor, F Fernandes, AMM Lino, LO Mendonça, FS Seguro, VA Feitosa, ...Orphanet Journal of Rare Diseases 7 (), -0, 2022202
1
2022
Risk factors for long COVID among healthcare workers, Brazil, 2020&2022
AR Marra, V Sampaio, MC Ozahata, RLP da Silva, A Brito, M Bragatte, ...medRxiv, 2023.0. 03.22284043, 2023202
1
2023